Previous close | 10.17 |
Open | 10.17 |
Bid | 8.50 |
Ask | 12.45 |
Strike | 17.50 |
Expiry date | 2023-10-20 |
Day's range | 10.17 - 10.17 |
Contract range | N/A |
Volume | |
Open interest | 5 |
In the volatile world of stock trading, healthcare companies Novavax (NASDAQ:NVAX) and Invitae (NYSE:NVTA) have been making headlines as they navigate significant financial challenges. Both firms are taking measures to reduce costs, aiming to improve their financial standing and appeal to a broader range of investors.
Clinical data from studies on Moderna's (MRNA) updated COVID vaccine shows improved antibody responses against multiple circulating variants, including BA.2.86, EG.5 and FL.1.5.1 variants.
COVID hospitalizations are rising, but they're nowhere near the levels they were at a year or two ago.